UAG
GILD icon

United Advisor Group’s Gilead Sciences GILD Stock Holding History

United Advisor Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$217K Buy
+1,559
New +$218K 0.03% 472
2025
Q2 		– Sell
-3,892
Closed -$436K – 389
2025
Q1 		$436K Buy
+3,892
New +$402K 0.09% 207

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

United Advisor Group's GILD Position: Q1 2026 in Review

United Advisor Group opened a new position in Gilead Sciences (GILD) in Q1 2026: 1,559 shares worth $217K. The stake represents 0.03% of the portfolio and ranks #472 among its holdings. This is a return to the name: United Advisor Group previously reported a position in GILD as recently as Q1 2025.

United Advisor Group first reported a position in GILD in Q1 2025 and has held it in 2 quarters since. The position peaked at $436K in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • United Advisor Group held 1,559 shares of Gilead Sciences worth $217K as of Q1 2026.
  • Gilead Sciences was a new United Advisor Group position in Q1 2026.
  • Gilead Sciences made up 0.03% of United Advisor Group's portfolio in Q1 2026, its #472 holding.
  • United Advisor Group first reported a position in Gilead Sciences in Q1 2025 and has held it in 2 quarters since.
  • United Advisor Group's Gilead Sciences position peaked at $436K in Q1 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on United Advisor Group's 13F filing for Q1 2026, filed 17 Apr 2026.